The rising adoption of PTFE in implantable prosthetic heart valve rings is expected to stimulate market demand.
Market Size in 2019 - USD 388.85 Million, Market Growth - CAGR of 3.8% over the forecast period, Market Trends -The use of PTFE in the guided tissue regeneration process is a major factor for the growth of the medical PTFE market.
The Global Medical Polytetrafluoroethylene Market size is expected to reach USD 523.40 million by 2027, according to the latest report. There has been a considerable increase in the application of fluoropolymers in the medical industry. Fluoropolymers such as PTFE are replacing plastics, metals, and ceramics in clinical applications. A clinical report called ‘Biomaterials for Periodontal Regeneration’ showed that e-PTFE is being used widely instead of calcium sulfate membrane positions in periodontal operations.
PTFE has registered increased adoption in the medical industry, chiefly in the dental sector. In dental implants, the PTFE membrane creates an obstruction and prevents the gums from growing within the bone cavity. During post-extraction bone regeneration, dense PTFE membranes are used in making dental implants. According to the American Society for Prosthodontics, approximately 52 % of the U.S. adults often suffer from periodontal disorders, and around 190 million adults by 2025 in the U.S. will be facing a partial tooth loss problem. Rising cases of dental injuries are expected to expand the application of PTFE membranes by dental surgeons.
The European medical PTFE market is projected to grow significantly in the forecast period. The market is expected to grow at a CAGR of 3.4% in the coming years. In Europe, PTFE is increasingly being adopted in the medical sector. The increasing incidence of periodontics is estimated to drive guided tissue regeneration demand for dental regeneration therapy. In 2013, over 50% of the European population suffered from some form of periodontitis, and over 10% have severe disease, with prevalence increasing to 70-85% of the population aged 60-65 years of age.
Further key findings from the report suggest
Segments covered in the report:
For the purpose of this report, Reports and Data has segmented the Global Medical Polytetrafluoroethylene on the basis of form, application, and region:
Form Outlook (Revenue, USD Million; 2017-2027)
Application Outlook (Revenue, USD Million; 2017-2027)
Regional Outlook (Revenue, USD Billion, 2017-2027)
Reasons to Buy the Report
Market Size in 2019 - USD 388.85 Million, Market Growth - CAGR of 3.8% over the forecast period, Market Trends -The use of PTFE in the guided tissue regeneration process is a major factor for the growth of the medical PTFE market.
The Global Medical Polytetrafluoroethylene Market size is expected to reach USD 523.40 million by 2027, according to the latest report. There has been a considerable increase in the application of fluoropolymers in the medical industry. Fluoropolymers such as PTFE are replacing plastics, metals, and ceramics in clinical applications. A clinical report called ‘Biomaterials for Periodontal Regeneration’ showed that e-PTFE is being used widely instead of calcium sulfate membrane positions in periodontal operations.
PTFE has registered increased adoption in the medical industry, chiefly in the dental sector. In dental implants, the PTFE membrane creates an obstruction and prevents the gums from growing within the bone cavity. During post-extraction bone regeneration, dense PTFE membranes are used in making dental implants. According to the American Society for Prosthodontics, approximately 52 % of the U.S. adults often suffer from periodontal disorders, and around 190 million adults by 2025 in the U.S. will be facing a partial tooth loss problem. Rising cases of dental injuries are expected to expand the application of PTFE membranes by dental surgeons.
The European medical PTFE market is projected to grow significantly in the forecast period. The market is expected to grow at a CAGR of 3.4% in the coming years. In Europe, PTFE is increasingly being adopted in the medical sector. The increasing incidence of periodontics is estimated to drive guided tissue regeneration demand for dental regeneration therapy. In 2013, over 50% of the European population suffered from some form of periodontitis, and over 10% have severe disease, with prevalence increasing to 70-85% of the population aged 60-65 years of age.
Further key findings from the report suggest
- The rise in the occurrence of periodontal diseases is expected to boost the medical PTFE market. Based on a report by the Centers for Disease Control and Prevention, 47.2% of adults aged 30 years and older in the U.S. have some form of periodontal disease. Moreover, the incidence of periodontal disease is higher in men than women, 56.4% and 38.4%, respectively.
- The European market is forecast to grow at a CAGR of 3.4% in the coming years. The WHO estimates, in Europe, nearly 20% of the middle-aged population and about 40% of the geriatric population has a severe periodontal disease. In spite of a vast population suffering from dental problems, the fact is not widely acknowledged in Europe. Furthermore, the incidence of abdominal aortic aneurysm (AAA) in England and Wales has been increasing. A recent report suggested that the incidence of AAA was 7.6% in men and 4.2% for women in 2013.
- Saint Gobain, Donaldson Company, Markel, Zeus Inc., Sumitomo Electric, W.L.Gore & Associates Inc, Pall Corporation, Chukoh Chemical Industries Ltd.
- Donaldson Company is a leading player in the Medical PTFE market. With an expansive presence in the U.S., Europe, and the Asia Pacific, the company offers a wide range of PTFE filter applications under the Tetratex PTFE membrane. In 2017, the company’s net earnings amounted to USD 232.8 million.
Segments covered in the report:
For the purpose of this report, Reports and Data has segmented the Global Medical Polytetrafluoroethylene on the basis of form, application, and region:
Form Outlook (Revenue, USD Million; 2017-2027)
- Pastes
- Tubes
- Sheets
- Fabric
Application Outlook (Revenue, USD Million; 2017-2027)
- Grafts
- Sutures
- Dental
- Pharmaceutical
- Others
Regional Outlook (Revenue, USD Billion, 2017-2027)
- North America
- U.S.
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- India
- Latin America
- Brazil
- Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Medical Polytetrafluoroethylene (PTFE) Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Medical Polytetrafluoroethylene (PTFE) market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Medical Polytetrafluoroethylene Market Segmentation & Impact Analysis
Chapter 5. Medical Polytetrafluoroethylene Market By Form Type Insights & Trends
Chapter 6. Medical Polytetrafluoroethylene Market By Application Type Insights & Trends
Chapter 7. Medical Polytetrafluoroethylene Market Regional Outlook
Chapter 8. Competitive Landscape
Chapter 9. Company Profiles
Companies Mentioned
- Saint Gobain
- W.L.Gore & Associates Inc
- Donaldson Company
- Sumitomo Electric
- Pall Corporation
- Markel
- Zeus Inc.
- Chukoh Chemical Industries Ltd.
